India's Medicamen Biotech jumps on 10-year contract

Medicamen Biotech

20/02/2025 04:29

** Medicamen Biotech  MEBI.NS  rises as much as 5.3% to 523
rupees
    ** Co signs 10-year contract manufacturing deal with a
US-based pharma distributor and marketing firm; financials not
disclosed but 25% payment due upfront
    ** Over 12,000 shares traded as of 9:46 a.m. IST, over half
of their 30-day moving avg
    ** Stock last up 4.7%, cutting YTD losses to 3.1%

 (Reporting by Meenakshi Maidas in Bengaluru)
 ((meenakshi.maidas@thomsonreuters.com;))